This issue brief examines how the Trump Administration proposals to lower drug costs described in the Administration’s Blueprint affect Medicaid. These include proposals to change the Medicaid Drug Rebate Program, as well as other approaches.
- view as grid
- view as list
This factsheet discusses breast cancer screening and prevention services, and reviews the scope of private and public insurance coverage, as well as access to those services for women in the US.
The United States played a leading role in the international response to the 2014 Ebola outbreak in West Africa, providing the most financial support, mobilizing U.S. staff across the federal government, and jumpstarting international efforts to strengthen global health security. As this month’s new outbreak unfolds in the Democratic Republic…
The United States played a leading role in the international response to the 2014 Ebola outbreak in West Africa, providing the most financial support, mobilizing U.S. staff across the federal government, and jumpstarting international efforts to strengthen global health security. As this month’s new outbreak unfolds in the Democratic Republic of Congo (DRC), the U.S. so far is playing a more limited role.
This Issue Brief examines key differences and changes since 2014 that are shaping how the U.S. and international community are responding in the DRC.
This interactive map shows the status of all Section 1332 waivers requested by states. The Affordable Care Act (ACA) allows states to apply for innovation waivers to alter key ACA requirements in the individual and small group insurance markets and can be used to shore up fragile insurance markets, address unique state insurance market issues, or experiment with alternative models of providing coverage to state residents.
This fact sheet identifies key U.S. government global health positions and officials.
New Brief Examines Potential Effects of Public Charge Changes on Health Coverage for Citizen Children
The Trump Administration is pursuing changes that, for the first time, would allow the federal government to take into account the use of federal health, nutrition, and other non-cash public programs, including Medicaid and the Children’s Health Insurance Program (CHIP), when making a determination about whether someone is likely…
The Trump Administration is pursuing changes that, for the first time, would allow the federal government to take into account use of Medicaid, CHIP, subsidies for Marketplace coverage and other health, nutrition, and non-cash programs when making public charge determinations. These changes would likely lead to decreased participation in Medicaid, CHIP, Marketplace coverage, and other programs among legal immigrants and their citizen children, even though they would remain eligible.
This fact sheet examines the Gavi, the Vaccine Alliance (also known as Gavi), an independent, public-private partnership and multilateral funding mechanism that aims to increase access to immunization in poor countries, and explores the role the U.S. government plays in supporting the partnership.
Three firms Account for Over Half of All Medicare Part D Enrollees in 2018, and Pending Mergers Would Further Consolidate the Marketplace
In 2018, three Medicare Part D plan sponsors—UnitedHealth, Humana, and CVS Health—account for more than half of the program’s 43 million Part D enrollees (55%) and two-thirds of all stand-alone drug plan enrollees, indicating a marketplace that is dominated by a handful of major insurers, according to a new Kaiser…